CoroNerve surveillance study: new questions relating to vaccine
The CoroNerve Studies Group wishes to thank everyone who have submitted cases to the CoroNerve surveillance study which is assessing COVID-19-associated neurological and psychiatric conditions.
Case data already submitted to the study have led to a publication in Lancet Psychiatry and a new Case Report Form manuscript which is currently under review. All those who have submitted cases are cited and searchable by name in PubMed as members of the CoroNerve Studies Group.
This near real-time surveillance platform is more important than ever and Members are encouraged to continue reporting cases.
The recently updated survey is now capturing details of potential psychiatric and neuropsychiatric (as well as neurological) complications resulting from the SARS-CoV-2 vaccine in addition to COVID-19.
The survey only takes a few minutes to complete and is critical to building knowledge and research in this important field.
If you take part, you’ll be invited to fill in a more detailed Case Report Form with full clinical details which will take approximately 20-30 minutes to complete.
Back to 11 February 2021 Members' update.